Related Articles
CYP4A11 is involved in the development of nonalcoholic fatty liver disease via ROS‑induced lipid peroxidation and inflammation
bZIP transmembrane transcription factor CREBH: Potential role in non‑alcoholic fatty liver disease (Review)
Impact of cholesterol metabolism and the LXRα-SREBP-1c pathway on nonalcoholic fatty liver disease
Inhibition of JNK suppresses autophagy and attenuates insulin resistance in a rat model of nonalcoholic fatty liver disease
Abnormal metabolic processes involved in the pathogenesis of non‑alcoholic fatty liver disease (Review)